HUMACYTE INC (HUMA:NASDAQ)
$1.15 0.04 (3.6036%)
Analysed HUMACYTE INC (HUMA:NASDAQ) News Sources
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
12-05-2026
yahoo.com
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
13-05-2026
yahoo.com
Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates
13-05-2026
yahoo.com
Humacyte Reports Q1 2026 Results: Full Earnings Call Transcript
13-05-2026
yahoo.com
Humacyte Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
Humacyte (HUMA) Q1 2026 Earnings Transcript
13-05-2026
fool.com
Humacyte Inc (HUMA) Q1 2026 Earnings Call Highlights: Sales Surge and Strategic Expansions Amid ...
13-05-2026
yahoo.com
Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization
19-05-2026
yahoo.com
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
20-05-2026
yahoo.com
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
26-05-2026
yahoo.com
What is the current price of HUMACYTE INC (HUMA:NASDAQ)?
The current price of HUMACYTE INC (HUMA:NASDAQ) is $1.15.
HUMACYTE INC (HUMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of HUMACYTE INC (HUMA:NASDAQ) since the previous trading day is $0.04.
HUMACYTE INC (HUMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of HUMACYTE INC (HUMA:NASDAQ) since the previous trading day is 3.6036%.
What is the most recent average sentiment score for HUMACYTE INC (HUMA:NASDAQ)?
The most recent average sentiment score for HUMACYTE INC (HUMA:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for HUMACYTE INC (HUMA:NASDAQ)?
The most recent sentiment for HUMACYTE INC (HUMA:NASDAQ) is .
SEC-8K** Filing Available For HUMACYTE INC (HUMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.